Skip to main content
رجوع
KMTS logo

Kestra Medical Technologies, Ltd.

جودة البيانات: 100%
KMTS
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 20.70
▲ KWD 1.11 (5.67%)
القيمة السوقية: 1.21B
نطاق اليوم
KWD 18.87 KWD 20.86
نطاق 52 أسبوعًا
KWD 13.25 KWD 30.00
حجم التداول
512,537
متوسط 50 يوم / 200 يوم
KWD 23.97 / KWD 22.08
الإغلاق السابق
KWD 19.59

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -10.6 0.3
P/B 5.9 2.9
ROE % 3.7
Net Margin % -190.3 3.8
Rev Growth 5Y % 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 28.000 +35.3%
Low: KWD 24.000 High: KWD 30.000
ربحية السهم المستقبلية
-KWD 2.311
الإيرادات المقدّرة
93 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 -KWD 1.210
-KWD 1.237 – -KWD 1.176
270 M 2
FY2028 -KWD 1.770
-KWD 2.080 – -KWD 1.423
190 M 6
FY2027 -KWD 2.199
-KWD 2.302 – -KWD 2.053
130 M 4

النقاط الرئيسية

Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -101.20M
Capital intensive — 39.44% of revenue goes to capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)115.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-31.95%
Net Margin-190.28%
Op. Margin-177.85%

الأمان

Debt / Equity
0.22
Current Ratio6.72
Interest Coverage-13.75

التقييم

P/E Ratio
-10.62
P/B Ratio5.88
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 115.05% Revenue Growth (3Y) 179.99%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 59.82M Net Income (TTM) -113.81M
ROE N/A ROA -38.48%
Gross Margin 40.47% Operating Margin -177.85%
Net Margin -190.28% Free Cash Flow (TTM) -101.20M
ROIC -31.95% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.22 Current Ratio 6.72
Interest Coverage -13.75 Dividend Yield 0.00%
Valuation
P/E Ratio -10.62 P/B Ratio 5.88
P/S Ratio 20.20 PEG Ratio -0.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.21B Enterprise Value 1.02B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2020
Revenue 59.82M 27.81M 7.63M 0.0 0.0
Net Income -113.81M -94.12M -84.24M -34.10M -29.47M
EPS (Diluted) -5.13 -2.04 -1.75 -0.69 -0.59
Gross Profit 24.21M 362,000.0 -10.65M 0.0 0.0
Operating Income -106.38M -85.06M -80.42M -32.71M -29.32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2020
Total Assets 295.74M 45.95M 38.66M 30.52M 7.87M
Total Liabilities 90.34M 255.33M 156.23M 28.76M 4.02M
Shareholders' Equity 205.41M -209.38M -117.58M 1.77M 3.86M
Total Debt 44.31M 45.17M 39.13M 22.85M 452,000.0
Cash & Equivalents 237.60M 8.25M 14.81M 24.34M 5.76M
Current Assets 255.33M 14.91M 18.42M 26.20M 6.17M
Current Liabilities 37.98M 32.97M 36.74M 6.61M 4.02M